Zepbound will dominate obesity market following SURMOUNT-5 results, says analyst
According to key opinion leaders, positive SURMOUNT-5 results, alongside Lilly’s business strategy, means Zepbound is set to overtake competitors.
According to key opinion leaders, positive SURMOUNT-5 results, alongside Lilly’s business strategy, means Zepbound is set to overtake competitors.
Tesla has recorded its first ever drop in annual sales amid growing competition from Chinese rivals and a global slowdown in growth of electric vehicle sales.
The proposed cap restricts any single digital payment firm from processing more than 30% of the total UPI transaction volume.
One indicator has correctly forecasted full-year stock performance 84% of the time.
Neumora Therapeutics reported its experimental depression drug didn't meet expectations, and shares plunged.
The company is aiming to secure the ‘Medical Device Single Audit Program’ certification by this year.
Tesla shares sank Thursday morning after the electric vehicle maker reported fewer deliveries than analysts had expected for the fourth quarter.
Tutor Perini announced that former president Gary Smalley has taken over as CEO.
Tesla (TSLA) has officially failed to reach its 2024 delivery goal, according to the latest sales data released by the electric vehicle maker.
Traders in interest rate futures have increased the probability that Fed policymakers this month will hold the federal funds rate at its current level.